BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
aarti pharmalabs limited stock

AARTI PHARMALABS LIMITED Share Price

612 10.40 (1.72%)
Dec 13 2024 03:29 PM Pharmaceuticals NSE: AARTIPHARM

AARTI PHARMALABS LIMITED Share Price Update

As of the latest trading session, AARTI PHARMALABS LIMITED share price is currently at 612, which is up by 10.40 from its previous closing. Today, the stock has fluctuated between 588.75 and 615.65. Over the past year, AARTI PHARMALABS LIMITED has achieved a return of 25.66 %. In the last month alone, the return has been -6.15 %. Read More...

AARTI PHARMALABS LIMITED Performance

Day Range

Low588.75 High615.65
608.85

52 Week Range

Low 399.55 High 721.70
608.85

AARTI PHARMALABS LIMITED Share Price

13868

543748

AARTIPHARM

img img img img
No Data Available

Open Price

601.60

Prev. Close

601.60

Volume (Shares)

240710.00

Total traded value

1465.56

Upper Circuit

721.90

Lower Circuit

481.30

Note: The current prices & values are delayed, Login to your account for live updates.

AARTI PHARMALABS LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 5546.31
PE Ratio (TTM) 26.67
Book Value / Share 188.34
Beta 0.97
ROE 13.11%
EPS (TTM) 22.75
Dividend Yield 0.49%
Net Profit Qtr (Cr) 47.84

AARTI PHARMALABS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 377.29
Operating Expense 316.80
Net Profit 47.84
Net Profit Margin (%) 12.67
Earnings Per Share (EPS) 5.28
EBITDA 87.71
Effective Tax Rate (%) 24.59
Particulars JUN 2024 (Values in Cr)
Revenue 393.49
Operating Expense 332.37
Net Profit 47.14
Net Profit Margin (%) 11.97
Earnings Per Share (EPS) 5.20
EBITDA 85.76
Effective Tax Rate (%) 25.43
Particulars MAR 2024 (Values in Cr)
Revenue 414.82
Operating Expense 329.22
Net Profit 63.02
Net Profit Margin (%) 15.19
Earnings Per Share (EPS) 6.95
EBITDA 113.02
Effective Tax Rate (%) 30.95
Particulars DEC 2023 (Values in Cr)
Revenue 373.03
Operating Expense 306.06
Net Profit 48.19
Net Profit Margin (%) 12.91
Earnings Per Share (EPS) 5.32
EBITDA 88.73
Effective Tax Rate (%) 28.53
Particulars SEP 2023 (Values in Cr)
Revenue 356.14
Operating Expense 302.48
Net Profit 41.81
Net Profit Margin (%) 11.73
Earnings Per Share (EPS) 4.61
EBITDA 73.81
Effective Tax Rate (%) 22.09
Particulars MAR 2024 (Values in Cr)
Revenue 1502.13
Operating Expense 1238.62
Net Profit 200.65
Net Profit Margin (%) 13.35
Earnings Per Share (EPS) 22.14
EBITDA 357.15
Effective Tax Rate (%) 26.90
Particulars MAR 2023 (Values in Cr)
Revenue 1511.25
Operating Expense 1279.17
Net Profit 171.73
Net Profit Margin (%) 11.36
Earnings Per Share (EPS) 18.95
EBITDA 309.62
Effective Tax Rate (%) 26.40
Particulars MAR 2022 (Values in Cr)
Revenue 941.02
Operating Expense 809.80
Net Profit 106.73
Net Profit Margin (%) 11.34
Earnings Per Share (EPS) 11.78
EBITDA 182.29
Effective Tax Rate (%) 20.18
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.18
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 193.88
ROE % 13.08
ROCE % 16.60
Total Debt to Total Equity 0.15
EBITDA Margin 21.10
Particulars MAR 2023 (Values in Cr)
Book Value / Share 171.97
ROE % 13.14
ROCE % 16.07
Total Debt to Total Equity 0.19
EBITDA Margin 17.70
Particulars MAR 2022 (Values in Cr)
Book Value / Share 53646.60
ROE % 17.63
ROCE % 19.37
Total Debt to Total Equity 0.25
EBITDA Margin 17.46
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.12
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.09
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 178.92
ROE % 13.11
ROCE % 16.40
Total Debt to Total Equity 0.16
EBITDA Margin 23.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 158.74
ROE % 12.61
ROCE % 15.56
Total Debt to Total Equity 0.20
EBITDA Margin 20.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 49558.52
ROE % 16.62
ROCE % 18.00
Total Debt to Total Equity 0.25
EBITDA Margin 19.37
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.07
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share 9.25
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 24.06
Total Assets 2582.10
Total Liabilities 2582.10
Total Equity 1757.03
Share Outstanding 90626008
Price to Book Ratio 2.43
Return on Assets (%) 8.40
Return on Capital (%) 10.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.19
Total Assets 2244.02
Total Liabilities 2244.02
Total Equity 1558.48
Share Outstanding 90626008
Price to Book Ratio 1.73
Return on Assets (%) 8.62
Return on Capital (%) 10.91
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 83.27
Total Assets 2039.89
Total Liabilities 2039.89
Total Equity 1386.47
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) 5.99
Return on Capital (%) 7.09
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 0.25
Total Liabilities 0.25
Total Equity 0.22
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) -1.83
Return on Capital (%) -1.87
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.42
Total Assets 2296.91
Total Liabilities 2296.91
Total Equity 1621.45
Share Outstanding 90626008
Price to Book Ratio 2.43
Return on Assets (%) 8.73
Return on Capital (%) 10.72
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.37
Total Assets 1976.36
Total Liabilities 1976.36
Total Equity 1438.57
Share Outstanding 90626008
Price to Book Ratio 1.73
Return on Assets (%) 8.68
Return on Capital (%) 10.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 56.49
Total Assets 1826.83
Total Liabilities 1826.83
Total Equity 1284.27
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) 5.84
Return on Capital (%) 6.63
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 0.25
Total Liabilities 0.25
Total Equity 0.22
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) -1.83
Return on Capital (%) -2.03
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 0.25
Total Liabilities 0.25
Total Equity 0.23
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) -7.47
Return on Capital (%) -8.07
Particulars MAR 2024 (Values in Cr)
Net Income 300.49
Cash from Operations 273.29
Cash from Investing -214.56
Cash from Financing 9.72
Net change in Cash 11.51
Free Cash Flow 428.89
Particulars MAR 2023 (Values in Cr)
Net Income 260.77
Cash from Operations 312.49
Cash from Investing -157.80
Cash from Financing -163.46
Net change in Cash -71.15
Free Cash Flow 414.62
Particulars MAR 2022 (Values in Cr)
Net Income 155.38
Cash from Operations -22.57
Cash from Investing -138.73
Cash from Financing 260.38
Net change in Cash 77.94
Free Cash Flow 118.57
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2024 (Values in Cr)
Net Income 274.51
Cash from Operations 230.68
Cash from Investing -184.39
Cash from Financing 4.39
Net change in Cash 3.69
Free Cash Flow 376.64
Particulars MAR 2023 (Values in Cr)
Net Income 233.35
Cash from Operations 272.61
Cash from Investing -115.55
Cash from Financing -156.52
Net change in Cash -56.19
Free Cash Flow 371.53
Particulars MAR 2022 (Values in Cr)
Net Income 133.72
Cash from Operations -49.84
Cash from Investing -133.53
Cash from Financing 254.62
Net change in Cash 56.24
Free Cash Flow 86.18
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2020 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 610.90
  • 26 Days 634.50
  • 10 Days 620.50
  • 50 Days 630.10
  • 12 Days 621.40
  • 100 Days 625.80
  • 20 Days 629.20
  • 200 Days 537.00
608.27
PIVOT
First Resistance 618.53
Second Resistance 635.47
Third Resistance 645.73
First Support 591.33
Second Support 581.07
Third Support 564.13
RSI 42.56
MACD -13.03
Commodity Channel Index (CCI) -137.15
ADX 8.76
Williams % R -76.11

Over 1 Month

down

-6.15

Over 3 Months

down

-7.58

Over 6 Months

down

2.08

Over 1 Year

down

25.66

Over 3 Years

down

0.00

Over 5 Years

down

0.00

AARTI PHARMALABS LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

AARTI PHARMALABS LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
35.17
Promoter Holdings
46.1
FII
7.37
DII
11.34
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Life Insurance Corporation Of India Public Shareholding 5490515.0 6.06
Rashesh Chandrakant Gogri Shareholding of Promoter and Promoter Group 3834404.0 4.23
Anushakti Enterprise Private Limited Shareholding of Promoter and Promoter Group 2972700.0 3.28
Quant Mutual Fund - Quant Small Cap Fund Public Shareholding 2942410.0 3.25
Labdhi Business Trust (saswat Trusteeship Private Limited) Shareholding of Promoter and Promoter Group 2841504.0 3.14
Renil Rajendra Gogri Shareholding of Promoter and Promoter Group 2792750.0 3.08
Mirik Rajendra Gogri Shareholding of Promoter and Promoter Group 2793094.0 3.08
Jaya Chandrakant Gogri Shareholding of Promoter and Promoter Group 2691310.0 2.97
Hetal Gogri Gala Shareholding of Promoter and Promoter Group 2615548.0 2.89
Sarla Shantilal Shah Shareholding of Promoter and Promoter Group 2435830.0 2.69
Ntasain Discovery Master Fund Public Shareholding 2336903.0 2.58
Orchid Family Trust (relacion Trusteeship Services Private Limited) Shareholding of Promoter and Promoter Group 1486000.0 1.64
Tulip Family Trust (gloire Trusteeship Services Private Limited) Shareholding of Promoter and Promoter Group 1486000.0 1.64
Safechem Enterprises Private Limited Shareholding of Promoter and Promoter Group 1463000.0 1.61
Rajendra Vallabhaji Gogri Shareholding of Promoter and Promoter Group 1425900.0 1.57
Manomaya Business Trust (alabhya Trusteeship Private Limited) Shareholding of Promoter and Promoter Group 1308496.0 1.44
Nehal Garewal Shareholding of Promoter and Promoter Group 1122487.0 1.24
Nishant Pradip Shah Public Shareholding 997427.0 1.1
Morgan Stanley Investment Funds Emerging Leaders Equity Fund Public Shareholding 909590.0 1.0
Heena Family Private Trust (barclays Wealth Trustees India Private Limited) Shareholding of Promoter and Promoter Group 833859.0 0.92
Bhavna Family Private Trust (barclays Wealth Trustees India Pvt Ltd) Shareholding of Promoter and Promoter Group 804101.0 0.89
Nikhil Parimal Desai Shareholding of Promoter and Promoter Group 768754.0 0.85
Jasmine Family Trust (relacion Trusteeship Services Private Limited) Shareholding of Promoter and Promoter Group 687500.0 0.76
Alchemie Financial Services Limited Shareholding of Promoter and Promoter Group 673006.0 0.74
Lotus Family Trust (gloire Trusteeship Services Private Limited) Shareholding of Promoter and Promoter Group 624500.0 0.69
Manisha Rashesh Gogri Shareholding of Promoter and Promoter Group 550000.0 0.61
Aashay Rashesh Gogri Shareholding of Promoter and Promoter Group 550000.0 0.61
Aarnav Rashesh Gogri Shareholding of Promoter and Promoter Group 550000.0 0.61
Bhavna Shah Lalka Shareholding of Promoter and Promoter Group 513941.0 0.57
Arti Rajendra Gogri Shareholding of Promoter and Promoter Group 475256.0 0.52
Parimal Hasmukhlal Desai Shareholding of Promoter and Promoter Group 399571.0 0.44
Gogri Finserv Pvt. Ltd. Shareholding of Promoter and Promoter Group 337505.0 0.37
Ratanben Premji Gogri Shareholding of Promoter and Promoter Group 337807.0 0.37
Heena Bhatia Shareholding of Promoter and Promoter Group 322588.0 0.36
Rajendra Vallabhaji Gogri (huf) [karta-rajendra Vallabhaji Gogri] Shareholding of Promoter and Promoter Group 308274.0 0.34
Shantilal Tejshi Shah (huf)[karta-nehal Garewal] Shareholding of Promoter and Promoter Group 278881.0 0.31
Alchemie Finserv Pvt. Ltd. Shareholding of Promoter and Promoter Group 264105.0 0.29
Nikhil Holdings Private Limited Shareholding of Promoter and Promoter Group 180891.0 0.2
Indira Madan Dedhia Shareholding of Promoter and Promoter Group 182250.0 0.2
Mananjay Singh Garewal Shareholding of Promoter and Promoter Group 162510.0 0.18
Bhanu Pradip Savla Shareholding of Promoter and Promoter Group 155737.0 0.17
Chandrakant Vallabhaji Gogri Shareholding of Promoter and Promoter Group 155500.0 0.17
Monisha Bhatia Shareholding of Promoter and Promoter Group 121121.0 0.13
Shreya Suneja Shareholding of Promoter and Promoter Group 112500.0 0.12
Gunavanti Navin Shah Shareholding of Promoter and Promoter Group 86644.0 0.1
Aashyav Business Trust (alabhya Trusteeship Private Limited) Shareholding of Promoter and Promoter Group 37900.0 0.04
Jayesh Shah Shareholding of Promoter and Promoter Group 16416.0 0.02
Valiant Organics Limited Shareholding of Promoter and Promoter Group 7500.0 0.01
Dilesh Roadlines Pvt Ltd Shareholding of Promoter and Promoter Group 8318.0 0.01
Tarla Parimal Desai Shareholding of Promoter and Promoter Group 0.0 0.0
Pooja Renil Gogri Shareholding of Promoter and Promoter Group 382.0 0.0
Prasadi Yogesh Banatwala Shareholding of Promoter and Promoter Group 4245.0 0.0

AARTI PHARMALABS LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-16 2.0 Interim 2024-02-19 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About AARTI PHARMALABS LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by AARTI PHARMALABS LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Aarti Pharmalabs Ltd?

Answer Field

The share price of Aarti Pharmalabs Ltd for NSE is ₹ 612 and for BSE is ₹ 616.65.

What is the Market Cap of Aarti Pharmalabs Ltd?

Answer Field

The market cap of Aarti Pharmalabs Ltd for NSE is ₹ 55,46.31 Cr. and for BSE is ₹ 55,88.45 Cr. as of now.

What is the 52 Week High and Low of Aarti Pharmalabs Ltd?

Answer Field

The 52 Week High and Low of Aarti Pharmalabs Ltd for NSE is ₹ 721.70 and ₹ 399.55 and for BSE is ₹ 721.00 and ₹ 380.65.

How to Buy Aarti Pharmalabs Ltd share?

Answer Field

You can trade in Aarti Pharmalabs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Aarti Pharmalabs Ltd?

Answer Field

The 1 year returns on the stock has been 25.66%.

What is the Current Share Price of Aarti Pharmalabs Ltd?

Answer Field

Aarti Pharmalabs Ltd share price is for NSE ₹ 612 & for BSE ₹ 616.65 as on Dec 13 2024 03:29 PM.

What is the Market Cap of Aarti Pharmalabs Ltd Share?

Answer Field

The market cap of Aarti Pharmalabs Ltd for NSE ₹ 55,46.31 & for BSE ₹ 55,88.45 as on Dec 13 2024 03:29 PM.

What is the P/E Ratio of Aarti Pharmalabs Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM the price-to-earnings (PE) ratio for Aarti Pharmalabs Ltd share is 26.67.

What is the PB ratio of Aarti Pharmalabs Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM, the price-to-book (PB) ratio for Aarti Pharmalabs Ltd share is 188.34.

How to Buy Aarti Pharmalabs Ltd Share?

Answer Field

You can trade in Aarti Pharmalabs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aarti Pharmalabs Ltd Share on Bajaj Broking App?

Answer Field

To buy Aarti Pharmalabs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aarti Pharmalabs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader